Biotech Values

[jq1234]

ABBV made three offers to SHPG since early May, rejected by SHPG Board

LONDON, June 19, 2014 /PRNewswire/ -- AbbVie Inc. ("AbbVie") notes the recent press speculation and confirms it made an indicative approach to Shire plc ("Shire") with a merger proposal which was rejected by the Board of Shire. There can be no certainty that any firm offer will be made. Discussions are no longer ongoing.

AbbVie's initial cash and share proposal in early May 2014 represented an indicative offer of £39.50 for each Shire share.[1] AbbVie's third and latest cash and share proposal when made represented an indicative offer of £46.26 for each Shire share.[2]

http://abbvie.mediaroom.com/2014-06-19-NOT-FOR-RELEASE-PUBLICATION-OR-DISTRIBUTION-IN-WHOLE-OR-IN-PART-DIRECTLY-OR-INDIRECTLY-IN-INTO-OR-FROM-ANY-JURISDICTION-WHERE-TO-DO-SO-WOULD-CONSTITUTE-A-VIOLATION-OF-THE-RELEVANT-LAWS-OR-REGULATIONS-OF-SUCH-JURISDICTION